Waltham, Massachusetts-based medical aesthetics company AVAVA has closed $45 million in growth financing led by Catalio Capital Management, splitting the round between $30 million of equity and a $15 million debt facility, the company said on September 17. The capital will accelerate commercial expansion of its MIRIA laser platform, designed to work safely across every Fitzpatrick skin tone — a market gap that legacy fractional lasers have never fully closed.
Depth-Controlled Energy, Not More Power
MIRIA is built around AVAVA's proprietary Focal Point Technology, which focuses laser energy beneath the skin surface at a controlled depth rather than driving higher fluence into the epidermis. The system already has FDA clearances covering acne scar treatment and dyspigmentation such as melasma, and the company is rolling out an AVAVA 2.0 software upgrade to expand indications.
"This financing gives us additional resources to scale our business, advance our innovation pipeline and bring AVAVA technology to more providers and patients around the world," AVAVA's chief executive said in the announcement. Catalio, which was already an investor, now anchors a syndicate that has committed north of $80 million to the company since 2024.
Why This Round Matters For Medtech
Aesthetic device makers historically have struggled to serve darker skin types, where existing lasers risk post-inflammatory hyperpigmentation. Underwriters treat safe efficacy across Fitzpatrick IV–VI as both a compliance and a growth story. AVAVA now sits alongside FDA-cleared robotic and imaging platforms redefining precision medicine — from Neptune Medical's Triton 1 robotic colonoscope and Medtronic's LigaSure RAS Maryland on Hugo to Altis Labs' AI oncology imaging endpoints.
What's Next
AVAVA plans to expand MIRIA's clinical indications, invest in software and clinician training, and enter new international geographies through the balance of 2027. Executives said the debt tranche gives the company flexibility to fund inventory buildout without diluting equity as installed-base sales accelerate.
Reporting based on coverage from GlobeNewswire, Catalio Capital, and BusinessWire.